Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes

Yoshiteru Azuma, Ana Töpf, Teresinha Evangelista, Paulo José Lorenzoni, Andreas Roos, Pedro Viana, Hidehito Inagaki, Hiroki Kurahashi, Hanns Lochmüller

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To identify the genetic cause in a patient affected by ptosis and exercise-induced muscle weakness and diagnosed with congenital myasthenic syndromes (CMS) using whole-genome sequencing (WGS). Methods: Candidate gene screening and WGS analysis were performed in the case. Allele-specific PCR was subsequently performed to confirm the copy number variation (CNV) that was suspected from the WGS results. Results: In addition to the previously reported frameshift mutation c.1124-1127dup, an intragenic 6,261 bp deletion spanning from the 5′ untranslated region to intron 2 of the DOK7 gene was identified by WGS in the patient with CMS. The heterozygous deletion was suspected based on reduced coverage on WGS and confirmed by allele-specific PCR. The breakpoints had microhomology and an inverted repeat, which may have led to the development of the deletion during DNA replication. Conclusions: We report a CMS case with identification of the breakpoints of the intragenic DOK7 deletion using WGS analysis. This case illustrates that CNVs undetected by Sanger sequencing may be identified by WGS and highlights their relevance in the molecular diagnosis of a treatable neurologic condition such as CMS.

Original languageEnglish
Article numbere152
JournalNeurology: Genetics
Volume3
Issue number3
DOIs
Publication statusPublished - 01-07-2017

Fingerprint

Congenital Myasthenic Syndromes
Genome
Alleles
Polymerase Chain Reaction
Frameshift Mutation
5' Untranslated Regions
Muscle Weakness
DNA Replication
Introns
Nervous System
Genes
Exercise

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Azuma, Y., Töpf, A., Evangelista, T., Lorenzoni, P. J., Roos, A., Viana, P., ... Lochmüller, H. (2017). Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes. Neurology: Genetics, 3(3), [e152]. https://doi.org/10.1212/NXG.0000000000000152
Azuma, Yoshiteru ; Töpf, Ana ; Evangelista, Teresinha ; Lorenzoni, Paulo José ; Roos, Andreas ; Viana, Pedro ; Inagaki, Hidehito ; Kurahashi, Hiroki ; Lochmüller, Hanns. / Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes. In: Neurology: Genetics. 2017 ; Vol. 3, No. 3.
@article{e8cb73153178411b8efe0275bd2a27c3,
title = "Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes",
abstract = "Objective: To identify the genetic cause in a patient affected by ptosis and exercise-induced muscle weakness and diagnosed with congenital myasthenic syndromes (CMS) using whole-genome sequencing (WGS). Methods: Candidate gene screening and WGS analysis were performed in the case. Allele-specific PCR was subsequently performed to confirm the copy number variation (CNV) that was suspected from the WGS results. Results: In addition to the previously reported frameshift mutation c.1124-1127dup, an intragenic 6,261 bp deletion spanning from the 5′ untranslated region to intron 2 of the DOK7 gene was identified by WGS in the patient with CMS. The heterozygous deletion was suspected based on reduced coverage on WGS and confirmed by allele-specific PCR. The breakpoints had microhomology and an inverted repeat, which may have led to the development of the deletion during DNA replication. Conclusions: We report a CMS case with identification of the breakpoints of the intragenic DOK7 deletion using WGS analysis. This case illustrates that CNVs undetected by Sanger sequencing may be identified by WGS and highlights their relevance in the molecular diagnosis of a treatable neurologic condition such as CMS.",
author = "Yoshiteru Azuma and Ana T{\"o}pf and Teresinha Evangelista and Lorenzoni, {Paulo Jos{\'e}} and Andreas Roos and Pedro Viana and Hidehito Inagaki and Hiroki Kurahashi and Hanns Lochm{\"u}ller",
year = "2017",
month = "7",
day = "1",
doi = "10.1212/NXG.0000000000000152",
language = "English",
volume = "3",
journal = "Neurology: Genetics",
issn = "2376-7839",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes. / Azuma, Yoshiteru; Töpf, Ana; Evangelista, Teresinha; Lorenzoni, Paulo José; Roos, Andreas; Viana, Pedro; Inagaki, Hidehito; Kurahashi, Hiroki; Lochmüller, Hanns.

In: Neurology: Genetics, Vol. 3, No. 3, e152, 01.07.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes

AU - Azuma, Yoshiteru

AU - Töpf, Ana

AU - Evangelista, Teresinha

AU - Lorenzoni, Paulo José

AU - Roos, Andreas

AU - Viana, Pedro

AU - Inagaki, Hidehito

AU - Kurahashi, Hiroki

AU - Lochmüller, Hanns

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Objective: To identify the genetic cause in a patient affected by ptosis and exercise-induced muscle weakness and diagnosed with congenital myasthenic syndromes (CMS) using whole-genome sequencing (WGS). Methods: Candidate gene screening and WGS analysis were performed in the case. Allele-specific PCR was subsequently performed to confirm the copy number variation (CNV) that was suspected from the WGS results. Results: In addition to the previously reported frameshift mutation c.1124-1127dup, an intragenic 6,261 bp deletion spanning from the 5′ untranslated region to intron 2 of the DOK7 gene was identified by WGS in the patient with CMS. The heterozygous deletion was suspected based on reduced coverage on WGS and confirmed by allele-specific PCR. The breakpoints had microhomology and an inverted repeat, which may have led to the development of the deletion during DNA replication. Conclusions: We report a CMS case with identification of the breakpoints of the intragenic DOK7 deletion using WGS analysis. This case illustrates that CNVs undetected by Sanger sequencing may be identified by WGS and highlights their relevance in the molecular diagnosis of a treatable neurologic condition such as CMS.

AB - Objective: To identify the genetic cause in a patient affected by ptosis and exercise-induced muscle weakness and diagnosed with congenital myasthenic syndromes (CMS) using whole-genome sequencing (WGS). Methods: Candidate gene screening and WGS analysis were performed in the case. Allele-specific PCR was subsequently performed to confirm the copy number variation (CNV) that was suspected from the WGS results. Results: In addition to the previously reported frameshift mutation c.1124-1127dup, an intragenic 6,261 bp deletion spanning from the 5′ untranslated region to intron 2 of the DOK7 gene was identified by WGS in the patient with CMS. The heterozygous deletion was suspected based on reduced coverage on WGS and confirmed by allele-specific PCR. The breakpoints had microhomology and an inverted repeat, which may have led to the development of the deletion during DNA replication. Conclusions: We report a CMS case with identification of the breakpoints of the intragenic DOK7 deletion using WGS analysis. This case illustrates that CNVs undetected by Sanger sequencing may be identified by WGS and highlights their relevance in the molecular diagnosis of a treatable neurologic condition such as CMS.

UR - http://www.scopus.com/inward/record.url?scp=85052666480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052666480&partnerID=8YFLogxK

U2 - 10.1212/NXG.0000000000000152

DO - 10.1212/NXG.0000000000000152

M3 - Article

VL - 3

JO - Neurology: Genetics

JF - Neurology: Genetics

SN - 2376-7839

IS - 3

M1 - e152

ER -